Dual-Time-Point 18 F-FDG PET/CT for Differentiating a Chest Wall Hemangioma From a Malignant Metastasis.
Journal: Clinical Nuclear Medicine
Published:
Abstract
Dual-time-point 18 F-flluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) can be used to differentiate benign vascular tumors from other malignant growths. We present the case of a 70-year-old woman with a history of cervical carcinoma who was referred for PET/CT to examine a left chest wall tumor noted on CT, which involved the adjacent rib and pleura, thus raising the suspicion of metastasis. The chest wall tumor demonstrated moderate FDG uptake and further decreased uptake at the delayed-phase scanning, corresponding to biodistribution of FDG in the blood pool. These findings indicated a benign hemangioma rather than a metastasis.
Authors
Hsi-huei Lu, Nan-tsing Chiu
Relevant Conditions